Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
NCT02753881
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
DRUG:
whole liver lobe cTACE doxorubicin
DRUG:
superselective cTACE doxorubicin
Sponsor
Yale University